Devyser launches a new updated NGS assay to simplify thalassemia testing
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Thalassemias are inherited blood disorders characterized by abnormal hemoglobin production. Depending on the type and number of variants, the symptoms can vary from none to severe forms where stem cell transplantation is the only curative treatment. Today, many different methods are available for variant analysis of thalassemia patients.
In this whitepaper by Mehmet Uzunel Ph.D., Devyser, Stockholm, Sweden, demonstrates an amplicon based NGS method using only ONE oligo-mix to detect virtually all known variants for alpha and beta thalassemia.
Thalassemias are inherited blood disorders characterized by abnormal hemoglobin production. Depending on the type and number of variants, the symptoms can vary from none to severe forms where stem cell transplantation is the only curative treatment. Today, many different methods are available for variant analysis of thalassemia patients.
In this whitepaper by Mehmet Uzunel Ph.D., Devyser, Stockholm, Sweden, demonstrates an amplicon based NGS method using only ONE oligo-mix to detect virtually all known variants for alpha and beta thalassemia.
Devyser has launched Devyser Thalassemia v2, a next-generation sequencing (NGS) solution designed...
Read More
Thalassemia and hemoglobinopathies are among the most common genetic disorders worldwide, affecting...
Read More
Read More
Read More